ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma.
- DOI
- 10.1002/1545-5017.70662
- Published
- 2026 Nov
- Container
- Pediatric blood & cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/1545-5017.70662,
title = {ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma.},
author = {Sabnis HS and Pauly M and Schafer ES and Norris RE and Ginn K and Yeung T and Kumar N and Senn S and Cowan H and DeRyckere D and Forlenza CJ and Shukla N},
year = {2026},
journal = {Pediatric blood \& cancer},
doi = {10.1002/1545-5017.70662},
url = {https://doi.org/10.1002/1545-5017.70662}
}RIS
TY - JOUR TI - ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma. AU - Sabnis HS AU - Pauly M AU - Schafer ES AU - Norris RE AU - Ginn K AU - Yeung T AU - Kumar N AU - Senn S AU - Cowan H AU - DeRyckere D AU - Forlenza CJ AU - Shukla N PY - 2026 JO - Pediatric blood & cancer DO - 10.1002/1545-5017.70662 UR - https://doi.org/10.1002/1545-5017.70662 ER -
APA
HS, S., M, P., ES, S., RE, N., K, G., T, Y., N, K., S, S., H, C., D, D., CJ, F., & N, S. (2026). ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma.. Pediatric blood & cancer. https://doi.org/10.1002/1545-5017.70662
Source records
- pubmed · retrieved 2026-09-25T05:27:58.749Z